SG11201610897VA - Methods for treating hypotension - Google Patents

Methods for treating hypotension

Info

Publication number
SG11201610897VA
SG11201610897VA SG11201610897VA SG11201610897VA SG11201610897VA SG 11201610897V A SG11201610897V A SG 11201610897VA SG 11201610897V A SG11201610897V A SG 11201610897VA SG 11201610897V A SG11201610897V A SG 11201610897VA SG 11201610897V A SG11201610897V A SG 11201610897VA
Authority
SG
Singapore
Prior art keywords
methods
treating hypotension
hypotension
treating
Prior art date
Application number
SG11201610897VA
Inventor
George Tidmarsh
Original Assignee
Jolla Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Pharma filed Critical Jolla Pharma
Publication of SG11201610897VA publication Critical patent/SG11201610897VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SG11201610897VA 2014-07-08 2015-07-08 Methods for treating hypotension SG11201610897VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462022054P 2014-07-08 2014-07-08
PCT/US2015/039499 WO2016007589A1 (en) 2014-07-08 2015-07-08 Methods for treating hypotension

Publications (1)

Publication Number Publication Date
SG11201610897VA true SG11201610897VA (en) 2017-01-27

Family

ID=55064810

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201610897VA SG11201610897VA (en) 2014-07-08 2015-07-08 Methods for treating hypotension
SG10201804034QA SG10201804034QA (en) 2014-07-08 2015-07-08 Methods for treating hypotension

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201804034QA SG10201804034QA (en) 2014-07-08 2015-07-08 Methods for treating hypotension

Country Status (14)

Country Link
US (3) US20160074465A1 (en)
EP (2) EP3381465A1 (en)
JP (2) JP2017519799A (en)
KR (1) KR20170026486A (en)
CN (1) CN106794224A (en)
AU (2) AU2015287955A1 (en)
BR (1) BR112017000303A2 (en)
CA (1) CA2954016A1 (en)
EA (2) EA202091873A3 (en)
IL (1) IL249936A0 (en)
MX (1) MX2017000306A (en)
SG (2) SG11201610897VA (en)
TW (3) TW202214219A (en)
WO (1) WO2016007589A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
ES2771749T3 (en) * 2013-12-18 2020-07-07 The George Washington Univ A Congressionally Chartered Not For Profit Corporation Angiotensin II in combination for the treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
WO2017120438A1 (en) 2016-01-07 2017-07-13 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
WO2018191678A1 (en) * 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
WO2019118874A1 (en) * 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto
WO2019183416A1 (en) 2018-03-23 2019-09-26 Nevakar Inc. Epinephrine compositions and containers
KR102258546B1 (en) 2018-10-26 2021-06-01 양성심 Health functional food composition comprising organic cale as main component

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
CN101316626A (en) * 2005-09-29 2008-12-03 菲布罗根公司 Methods for reducing blood pressure
US20100172862A1 (en) * 2008-11-28 2010-07-08 Abbott Laboratories Stable antibody compositions and methods of stabilizing same
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
ES2771749T3 (en) * 2013-12-18 2020-07-07 The George Washington Univ A Congressionally Chartered Not For Profit Corporation Angiotensin II in combination for the treatment of hypotension

Also Published As

Publication number Publication date
TW202214219A (en) 2022-04-16
EP3007722A4 (en) 2016-05-25
US20200237853A1 (en) 2020-07-30
EA201692534A1 (en) 2017-06-30
CA2954016A1 (en) 2016-01-14
BR112017000303A2 (en) 2017-11-07
TW201625231A (en) 2016-07-16
TWI754225B (en) 2022-02-01
WO2016007589A1 (en) 2016-01-14
US20180311306A1 (en) 2018-11-01
EA202091873A3 (en) 2021-01-29
JP2017519799A (en) 2017-07-20
TWI688385B (en) 2020-03-21
US20160074465A1 (en) 2016-03-17
CN106794224A (en) 2017-05-31
EP3007722A1 (en) 2016-04-20
KR20170026486A (en) 2017-03-08
EA202091873A2 (en) 2020-11-30
AU2021201669A1 (en) 2021-04-08
AU2015287955A1 (en) 2017-02-02
EA036514B1 (en) 2020-11-18
SG10201804034QA (en) 2018-07-30
TW202038927A (en) 2020-11-01
IL249936A0 (en) 2017-03-30
JP2020143139A (en) 2020-09-10
EP3381465A1 (en) 2018-10-03
MX2017000306A (en) 2017-07-10

Similar Documents

Publication Publication Date Title
IL304252A (en) Method for treating cancer
IL289947A (en) Method for treating cancer
GB201406151D0 (en) Method
GB201406155D0 (en) Method
GB201408119D0 (en) Method
HK1245804A1 (en) Anti-csf1r antibodies for treating pvns
HK1244217A1 (en) Methods for treating proteinopathies
IL249936A0 (en) Methods for treating hypotension
IL249475A0 (en) Methods for treating pruritus
HK1248133A1 (en) Methods for treating neuroblastoma
GB201403470D0 (en) Method
PL3186013T3 (en) Device for treating objects
GB201410101D0 (en) Method
ZA201607068B (en) Methods for treating hypersomnia
GB201409101D0 (en) Method
IL249616A0 (en) Methods for treating infections
GB201408649D0 (en) Method
GB201409067D0 (en) Method
GB201408160D0 (en) Method
GB201407971D0 (en) Method
GB201407948D0 (en) Method
GB201407809D0 (en) Method
GB201407815D0 (en) Method
GB201406509D0 (en) Method
GB201406399D0 (en) Method